Botulinum toxin A may improve skin-related quality of life in patients with cutaneous leiomyomas, according to Maryland-based researchers. As Dr. Edward W. Cowen told Reuters Health by email, "In this small pilot study, we provide preliminary evidence that botulinum toxin improves quality of life and may exhibit analgesic qualities in patients with significant pain related to cutaneous leiomyomas. To our knowledge, this is the first clinical trial demonstrating such a benefit with botulinum toxin for leiomyoma skin-related pain."

He further pointed out, "Cutaneous leiomyomas are benign smooth muscle proliferations that are associated with pain that is typically not well-controlled by topical remedies or systemic pain medication. Hereditary leiomyomatosis and renal cell cancer is a rare syndrome in which patients may have dozens or even hundreds of these painful tumors. We sought to determine if botulinum toxin injected directly into leiomyomas may ameliorate discomfort and improve quality of life in patients who experience significant pain from cutaneous leiomyomas."

To read the entire article, click on the link below.

Merz North America, US affiliate of the global Merz Pharma Group, announces that Radiesse® has received U.S. FDA approval for hand augmentation to correct volume loss in the dorsum of the hands. Radiesse® provides an immediate volumizing effect and can help to reduce the prominence of tendons and veins in the hands1, delivering smooth, natural-looking results that can last up to 1 year.

To read the entire press release, click on the link below.

This month we are offering a $50 credit to models who register for our training seminar being held in Omaha, NEon September 19, 2015.

Register by clicking on the link above and enter NEWSLETTER in the notes section, or give us a call at (512) 301-2125.